Specific bone-protective effects of metabolites/derivatives of tamoxifen and clomiphene in ovariectomized rats

Bone

Volumn 23, Issue 6, 1998, Pages 537-542

  Ruenitz, P C ^a   Shen, Y ^b   Li, M ^b   Liang, H ^b   Whitehead Jr , R D ^a   Pun, S ^b   Wronski, T J ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b University of Florida College of Veterinary Medicine   (United States)

Author keywords

Antiestrogen; Clomiphene; Estrogen; Osteopenia; Osteoporosis; Tamoxifen

Indexed keywords

4 HYDROXYTAMOXIFEN; ANTIESTROGEN; CLOMIFENE; ESTRADIOL; TAMOXIFEN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE; BONE ATROPHY; BONE TURNOVER; CONTROLLED STUDY; FEMALE; NONHUMAN; OVARIECTOMY; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; UTERUS;

ANIMALS; BODY WEIGHT; BONE RESORPTION; CLOMIPHENE; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; OSTEOCALCIN; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; TAMOXIFEN; TIBIA; UTERUS;

EID: 0032401682     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(98)00137-9     Document Type: Article

References (42)

1. Baron R., Vignery A., Neff L., Silvergate A., Santa Maria A. Processing of undecalcified bone specimens for bone histomorphometry. Recker R.R. Bone Histomorphometry Techniques and Interpretation . 1983;13-35 CRC, Boca Raton, FL.
2. Beall P.T., Misra L.K., Young R.L., Spjut H.J., Evans H.J., LeBlanc A. Clomiphene protects against osteoporosis in the mature ovariectomized rat. Calcif Tissue Int. 36:1984;123-125.
3. Brubaker K.D., Gay C.V. Specific binding of estrogen to osteoclast surfaces. Biochem Biophys Res Commun. 200:1994;899-907.
4. Buring J.E., Bain C.J., Ehrmann R.L. Conjugated estrogen use and risk of endometrial cancer. Am J Epidemiol. 124:1986;434-441.
5. Caselli G., Mantovanini M., Gandolfi C.A., Allegretti M., Fiorentino S., Pellegrini L., Melillo G., Bertini R., Sabbatini W., Anacardio R., Clavenna G., Sciortino G., Teti A. Tartronates - a new generation of drugs affecting bone metabolism. J Bone Miner Res. 12:1997;972-981.
6. Delmas P.D., Malaval L., Arlot M.E., Meunier P.J. Serum bone gla-protein compared to bone histomorphometry in endocrine diseases. Bone. 6:1985;339-341.
7. Dukes M., Chester R., Yarwood L., Wakeling A.E. Effects of a non-steroidal pure antiestrogen, ZM 189,154 on estrogen target organs of the rat including bones. J Endocrinol. 141:1994;335-341.
8. Eriksen E.F., Colvard D.S., Berg N.J., Graham M.L., Mann K.G., Spelsberg T.C., Riggs B.L. Evidence of estrogen receptors in normal human osteoblast-like cells. Science. 241:1988;84-86.
9. Fornander T., Rutqvist L.E., Sjoberg H.E., Blomqvist L., Mattsson A., Glas U. Long term tamoxifen in early breast cancer Effect on bone mineral density in postmenopausal women . J Clin Oncol. 8:1990;1019-1024.
10. Frolik C.A., Bryant H.U., Black E.C., Magee D.E., Chandrasekhar S. Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats Effects of raloxifene HCl, tamoxifen, estrogen, and alendronate . Bone. 18:1996;621-627.
11. Frost H.M. Bone histomorphometry Analysis of trabecular bone dynamics . Recker R.R. Bone Histomorphometry Techniques and Interpretation . 1983;109-132 CRC, Boca Raton, FL.
12. Gallagher A., Chambers T.J., Tobias J.H. The estrogen antagonist ICI 182,780 reduces cancellous bone volume in female rats. Endocrinology. 133:1993;2787-2791.
13. Grady D., Rubin S.M. The postmenopausal estrogen/breast cancer controversy. JAMA. 269:1993;990-991.
14. Hall T.J., Schaueblin M. Promethazine inhibits osteoclastic bone resorption in vitro. Calcif Tissue Int. 55:1994;68-70.
15. Jimenez M.A., Magee D.E., Bryant H.U., Turner R.T. Clomiphene prevents cancellous bone loss from tibia of ovariectomized rats. Endocrinology. 138:1997;1794-1800.
16. Katzenellenbogen J.A., O'Malley B.W., Katzenellenbogen B.S. Tripartite steroid hormone receptor pharmacology Interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones . Mol Endocrinol. 10:1996;119-131.
17. Ke H.Z., Chen H.K., Simmons H.A., Qi H., Crawford D.T., Pirie C.M., Chidsey-Frink K.L., Ma Y.F., Jee W.S.S., Thompson D.D. Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model. Bone. 20:1997;31-39.
18. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Häggblad J., Nilsson S., Gustafsson J. Å. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β Endocrinology. 138:1997;863-870.
19. Lin J.H., Duggan D.E., Chen I.-W., Ellsworth R.L. Physiological disposition of alendronate, a potent anti-osteolytic bisphosphonate, in laboratory animals. Drug Metab Dispos. 19:1991;926-932.
20. Love R.R., Mazess R.B., Tormey D.C., Barden H.S., Newcomb P.A., Jordan V.C. Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two years. Breast Cancer Res Treat. 12:1988;297-302.
21. Moon L.Y., Wakley G.K., Turner R.T. Dose-dependent effects of tamoxifen on long bones in growing rats Influence of ovarian status . Endocrinology. 129:1991;1568-1574.
22. Neter J., Wasserman W., Whitmore G.A. Applied Statistics. 1982;Allyn and Bacon, Boston.
23. Ruenitz P.C., Bagley J.R., Mokler C.M. Metabolism of clomiphene in the rat Estrogen receptor affinity and antiestrogenic activity of clomiphene metabolites . Biochem Pharmacol. 32:1983;2941-2947.
24. Ruenitz P.C., Bagley J.R., Watts C.K.W., Hall R.E., Sutherland R.L. Substituted-vinyl hydroxytriarylethylenes Synthesis and effects on MCF 7 breast cancer cell proliferation . J Med Chem. 29:1986;2511-2519.
25. Ruenitz P.C., Nanavati N.T. Identification and distribution in the rat of acidic metabolites of tamoxifen. Drug Metab Dispos. 18:1990;645-648.
26. Ruenitz P.C. Drugs for osteoporosis prevention. Mechanisms of bone maintenance. Curr Med Chem. 2:1995;791-802.
27. Ruenitz P.C., Bai X. Acidic metabolites of tamoxifen Aspects of formation and fate in the female rat . Drug Metab Dispos. 23:1995;993-998.
28. Ruenitz P.C., Bourne C.S., Sullivan K.J., Moore S.A. Estrogenic triarylethylene acetic acids Effect of structural variation on estrogen receptor affinity and estrogenic potency and efficacy in MCF-7 cells . J Med Chem. 39:1996;4853-4859.
29. Ruenitz P.C. Female sex hormones and analogs. Wolff M.E. Burger's Medicinal Chemistry and Drug Discovery, 5th Ed. Vol. 4:1997;553-587 Wiley, New York.
30. Schot L.P.C., Schuurs A.H.W. Sex steroids and osteoporosis Effects of deficiencies and substitutive treatments . J Ster Biochem Mol Biol. 37:1990;167-182.
31. Tarallo P., Henny J., Fournier B., Siest G. Plasma osteocalcin Biological variations and reference limits . Scand J Clin Lab Invest. 50:1990;649-655.
32. Turken S., Siris E., Seldin D., Flaster E., Hyman G., Lindsay R. Effects of tamoxifen on spinal bone density in women with breast cancer. J Natl Cancer Inst. 81:1989;1086-1088.
33. Turner R.T., Wakley G.K., Hannon K.S., Bell N.H. Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats. Endocrinology. 122:1988;1146-1150.
34. Tyan M.L. Effect of promethazine on lumbar vertebral bone mass in postmenopausal women. J Intern Med. 234:1993;143-148.
35. Watanabe T., Inoue S., Ogawa S., Ishii Y., Hiroi H., Ikeda K., Orimo A., Muramatsu M. Agonistic effect of tamoxifen is dependent on cell-type, ere-promoter context, and estrogen-receptor subtype - functional difference between estrogen-receptor-alpha and estrogen-receptor-beta. Biochem Biophys Res Commun. 236:1997;140-145.
36. Wiita B. Osteoporosis - causes and consequences. Curr Sci. 68:1995;446-450.
37. Williams D.C., Paul D.C., Black L.J. Effects of estrogen and tamoxifen on serum osteocalcin levels in ovariectomized rats. Bone Miner. 14:1991;205-220.
38. +-ATPase and bone resorption by tamoxifen and calmodulin antagonists Effects independent of steroid receptors . J Biol Chem. 271:1996;12488-12495.
39. Wilson S., Ruenitz P.C., Ruzicka J.A. Estrogen receptor affinity and effects on MCF-7 cell growth of triarylethylene carboxylic acids related to tamoxifen. J Ster Biochem Mol Biol. 42:1992;613-616.
40. Wronski T.J., Cintrón M., Doherty A.L., Dann L.M. Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology. 123:1988;681-686.
41. Wronski T.J., Dann L.M., Qi H., Yen C.F. Skeletal effects of withdrawal of estrogen and diphosphonate treatment in ovariectomized rats. Calcif Tissue Int. 53:1993;210-216.
42. Young R.L., Goldzieher J.W., Elkind-Hirsch K., Hickox P.G., Chakraborty P.K. A short-term comparison of the effects of clomiphene citrate and conjugated equine estrogen in menopausal/castrate women. Int J Fertil. 36:1991;167-171.